(Q30990773)

28 June 2017

title

Vitronectin in clotting factor IX concentrates (English)

1 reference

28 June 2017

Josic D

1

1 reference

28 June 2017

Kannicht C

2

1 reference

28 June 2017

Löster K

3

1 reference

28 June 2017

Pock K

4

1 reference

28 June 2017

Iberer G

5

1 reference

28 June 2017

Buchacher A

6

1 reference

28 June 2017

publication date

1 May 2001

1 reference

28 June 2017

1 reference

28 June 2017

volume

7

1 reference

28 June 2017

issue

3

1 reference

28 June 2017

page(s)

250-257

1 reference

Factor IX concentrates for clinical use.

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00503.X

No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00503.X

Improved virus safety and purity of a chromatographically produced Factor IX concentrate by nanofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00503.X

Factor IX concentrate versus prothrombin complex concentrate for the treatment of hemophilia B during surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00503.X

Thrombogenicity of prothrombin complex concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00503.X

Size-exclusion chromatography of plasma proteins with high molecular masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00503.X

Thrombin regulation by physiological inhibitors: the role of vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00503.X

The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00503.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00503.X

Human coagulation factor IX. Isolation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00503.X

Type 1 plasminogen activator inhibitor induces multimerization of plasma vitronectin. A suggested mechanism for the generation of the tissue form of vitronectin in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00503.X

10.1046/J.1365-2516.2001.00503.X

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference